search
Back to results

Washed Microbiota Transplantation for Malnutrition After Upper Gastrointestinal Rerouting Surgery

Primary Purpose

Malnutrition, Upper Gastrointestinal Rerouting Surgery

Status
Not yet recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
washed microbiota transplantation
Sponsored by
The Second Hospital of Nanjing Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Malnutrition focused on measuring washed microbiota transplantation, fecal microbiota transplant, malnutrition, enteral nutrition, cachexia, upper gastrointestinal rerouting surgery, delivery

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients undergone upper gastrointestinal rerouting surgery (Billroth-II or Roux-en-Y reconstruction);
  • Aged between 18 and 65 years old;
  • Weight loss > 5% over past 6 months (in absence of simple starvation) or weight loss > 2% in those who have a BMI < 20;
  • 20 g/L ≤ Albumin < 30 g/L;
  • Malnutrition as assessed by NRS2002 score ≥ 3;
  • Written informed consent.

Exclusion Criteria:

  • Expected survival time < 3 months;
  • Known organic gastrointestinal disease (e.g., gastrointestinal infection, inflammatory bowel disease, or radiation enteritis);
  • Still on anti-tumor therapy (chemotherapy, radiotherapy, immunotherapy);
  • Taking Antibiotics within four weeks before enrollment;
  • Complicated with contraindications of EN such as ileus, active gastrointestinal bleeding, and shock;
  • Cannot tolerate gastroscopy or colonoscopy;
  • Severe comorbidities (e.g., diabetes, cardiopulmonary failure, severe liver or kidney diseases);
  • Food intolerance;
  • Mental disorder;
  • Women who are pregnant or breastfeeding;
  • Participating in another clinical trial.

Sites / Locations

  • Medical Center for Digestive Diseases, Second Affiliated Hospital of Nanjing Medical University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

midgut

colonic

Arm Description

A soft TET tube is inserted into the colon via the paraffin-lubricated gastroscope channel. If patients cannot tolerate endoscopy or anesthesia, or it is difficult to confirm the bypass intestine under endoscopy, a nasojejunal tube will be inserted under digital fluoroscopy.

A soft TET tube is inserted into the colon via the paraffin-lubricated colonoscope channel.

Outcomes

Primary Outcome Measures

Clinical response rate
serum albumin ≥ 35 g/L
Clinical remission rate
body mass index (BMI) increased by 5% (weight and height will be combined to report BMI in kg/m^2)

Secondary Outcome Measures

Full Information

First Posted
June 19, 2022
Last Updated
June 30, 2022
Sponsor
The Second Hospital of Nanjing Medical University
Collaborators
Sir Run Run Hospital, Nanjing Medical University, Wuxi No. 2 People's Hospital, The First Affiliated Hospital of Guangdong Pharmaceutical University
search

1. Study Identification

Unique Protocol Identification Number
NCT05439135
Brief Title
Washed Microbiota Transplantation for Malnutrition After Upper Gastrointestinal Rerouting Surgery
Official Title
An Open-label, Multicenter, Randomized Clinical Trial for Malnutrition After Upper Gastrointestinal Rerouting Surgery: Washed Microbiota Transplantation Via Mid-gut Tube Versus Colonic Transendoscopic Enteral Tube
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 1, 2022 (Anticipated)
Primary Completion Date
June 1, 2023 (Anticipated)
Study Completion Date
July 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Second Hospital of Nanjing Medical University
Collaborators
Sir Run Run Hospital, Nanjing Medical University, Wuxi No. 2 People's Hospital, The First Affiliated Hospital of Guangdong Pharmaceutical University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a prospective, randomized, multicenter study to evaluate WMT in improving nutritional status in malnourished patients who underwent upper gastrointestinal rerouting surgery. In this multicenter trial, fifty-six patients will be enrolled in four Chinese sites. Participants will be randomized at a ratio of 1:1 to receive three WMTs through either mid-gut tube or colonic TET. After WMT, each participant will receive free diet plus 50% PEN. PEN should last for 4 weeks at home, with stool samples taken and stored at baseline, week 1, and 4 after WMT.
Detailed Description
Background: Malnutrition is a common complication of upper gastrointestinal rerouting surgery. The potential of washed microbiota transplantation (WMT) in improving nutritional status have been reported. The surgery procedure alters the anatomy and physiology of the digestive tract, which might impact the efficacy and safety of WMT when choosing different delivery way. This study aims to explore the optimal delivery of WMT in malnourished patients after rerouting of the upper gastrointestinal tract. Methods and design: This multicenter, open-label, and randomized controlled trial will be conducted at four tertiary hospitals in China. Enteral nutrition (EN) will be administrated at enrollment. Participants will be then randomized at a ratio of 1:1 to receive three WMTs through either mid-gut tube or colonic transendoscopic enteral tubing (TET). Then the patients will receive free diet coupled with partial enteral nutrition (PEN) for 4 weeks in both groups, with stool samples taken and stored at baseline, week 1, and 4 after WMT. The observation duration is 4 weeks. The primary outcomes include clinical response rate (serum albumin ≥ 35 g/L at week 4 after WMT) and clinical remission rate (body mass index increased by 5% at week 4 after WMT). The secondary outcomes include nutritional status, appetite, laboratory parameters, adverse events and comprehensive analysis of the fecal microbiota. Conclusion: It is estimated that WMT would help relieve emaciation and improve nutrition status. Moreover, this trial has the potential to identify the optimal delivery of WMT for patients undergoing upper gastrointestinal rerouting surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malnutrition, Upper Gastrointestinal Rerouting Surgery
Keywords
washed microbiota transplantation, fecal microbiota transplant, malnutrition, enteral nutrition, cachexia, upper gastrointestinal rerouting surgery, delivery

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
56 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
midgut
Arm Type
Experimental
Arm Description
A soft TET tube is inserted into the colon via the paraffin-lubricated gastroscope channel. If patients cannot tolerate endoscopy or anesthesia, or it is difficult to confirm the bypass intestine under endoscopy, a nasojejunal tube will be inserted under digital fluoroscopy.
Arm Title
colonic
Arm Type
Experimental
Arm Description
A soft TET tube is inserted into the colon via the paraffin-lubricated colonoscope channel.
Intervention Type
Other
Intervention Name(s)
washed microbiota transplantation
Other Intervention Name(s)
partial enteral nutrition
Intervention Description
Each patient will receive two units of washed microbiota each day for three consecutive days. After WMT, participants will receive free diet plus 50% PEN (providing 50% calculated energy requirement) at home for 4 weeks.
Primary Outcome Measure Information:
Title
Clinical response rate
Description
serum albumin ≥ 35 g/L
Time Frame
week 4 after WMT
Title
Clinical remission rate
Description
body mass index (BMI) increased by 5% (weight and height will be combined to report BMI in kg/m^2)
Time Frame
week 4 after WMT

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients undergone upper gastrointestinal rerouting surgery (Billroth-II or Roux-en-Y reconstruction); Aged between 18 and 65 years old; Weight loss > 5% over past 6 months (in absence of simple starvation) or weight loss > 2% in those who have a BMI < 20; 20 g/L ≤ Albumin < 30 g/L; Malnutrition as assessed by NRS2002 score ≥ 3; Written informed consent. Exclusion Criteria: Expected survival time < 3 months; Known organic gastrointestinal disease (e.g., gastrointestinal infection, inflammatory bowel disease, or radiation enteritis); Still on anti-tumor therapy (chemotherapy, radiotherapy, immunotherapy); Taking Antibiotics within four weeks before enrollment; Complicated with contraindications of EN such as ileus, active gastrointestinal bleeding, and shock; Cannot tolerate gastroscopy or colonoscopy; Severe comorbidities (e.g., diabetes, cardiopulmonary failure, severe liver or kidney diseases); Food intolerance; Mental disorder; Women who are pregnant or breastfeeding; Participating in another clinical trial.
Facility Information:
Facility Name
Medical Center for Digestive Diseases, Second Affiliated Hospital of Nanjing Medical University
City
Nanjing
State/Province
Jiangsu
ZIP/Postal Code
210011
Country
China

12. IPD Sharing Statement

Plan to Share IPD
Yes
Citations:
PubMed Identifier
19212169
Citation
Csendes A, Burgos AM, Smok G, Burdiles P, Braghetto I, Diaz JC. Latest results (12-21 years) of a prospective randomized study comparing Billroth II and Roux-en-Y anastomosis after a partial gastrectomy plus vagotomy in patients with duodenal ulcers. Ann Surg. 2009 Feb;249(2):189-94. doi: 10.1097/SLA.0b013e3181921aa1.
Results Reference
background
PubMed Identifier
34523717
Citation
Nishizaki D, Ganeko R, Hoshino N, Hida K, Obama K, Furukawa TA, Sakai Y, Watanabe N. Roux-en-Y versus Billroth-I reconstruction after distal gastrectomy for gastric cancer. Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD012998. doi: 10.1002/14651858.CD012998.pub2.
Results Reference
background
PubMed Identifier
23160295
Citation
Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol. 2012 Nov;107(11):1755; author reply p.1755-6. doi: 10.1038/ajg.2012.251. No abstract available.
Results Reference
background
PubMed Identifier
34746161
Citation
Xiang L, Yu Y, Ding X, Zhang H, Wen Q, Cui B, Zhang F. Exclusive Enteral Nutrition Plus Immediate vs. Delayed Washed Microbiota Transplantation in Crohn's Disease With Malnutrition: A Randomized Pilot Study. Front Med (Lausanne). 2021 Oct 22;8:666062. doi: 10.3389/fmed.2021.666062. eCollection 2021.
Results Reference
background
PubMed Identifier
31170412
Citation
Levine A, Wine E, Assa A, Sigall Boneh R, Shaoul R, Kori M, Cohen S, Peleg S, Shamaly H, On A, Millman P, Abramas L, Ziv-Baran T, Grant S, Abitbol G, Dunn KA, Bielawski JP, Van Limbergen J. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. 2019 Aug;157(2):440-450.e8. doi: 10.1053/j.gastro.2019.04.021. Epub 2019 Jun 4.
Results Reference
background
PubMed Identifier
27556065
Citation
Peng Z, Xiang J, He Z, Zhang T, Xu L, Cui B, Li P, Huang G, Ji G, Nie Y, Wu K, Fan D, Zhang F. Colonic transendoscopic enteral tubing: A novel way of transplanting fecal microbiota. Endosc Int Open. 2016 Jun;4(6):E610-3. doi: 10.1055/s-0042-105205. Epub 2016 Apr 28.
Results Reference
background

Learn more about this trial

Washed Microbiota Transplantation for Malnutrition After Upper Gastrointestinal Rerouting Surgery

We'll reach out to this number within 24 hrs